2025年上半年，集团总收益轻微增加，乃由于香港市场对眼科医疗服务需求增加，带动香港眼科服务收 益增长，惟部分被深圳牙科服务及眼科服务因激烈竞争导致收益减少所抵销的综合结果。 格隆汇8月26日丨希玛医疗(03309.HK)发布公告，截至2025年6月30日止六个月，实现收益9.44亿港元， 同比增加2.4%；毛利为2.94亿港元，同比增加1.7%；公司拥有人应占溢利为4994.4万港元，同比增加 62.4%；公司权益持有人应占期内经调整利润为6963.6万港元，同比增加74.5%；基本每股盈利4.11港 仙。 ...

Core Insights - Modern Dental announced a positive earnings forecast, leading to a 12.55% increase in stock price, currently at HKD 5.20 with a trading volume of HKD 6.0749 million [1] Financial Performance Summary - The company expects revenue for the first half of 2025 to be between HKD 1.775 billion and HKD 1.85 billion, representing an increase of approximately 4.3% to 8.7% compared to HKD 1.702 billion for the first half of 2024 [1] - EBITDA for the first half of 2025 is projected to be between HKD 430 million and HKD 470 million, an increase of approximately 14.5% to 25.1% from HKD 376 million in the first half of 2024 [1] - Net profit for the first half of 2025 is anticipated to be between HKD 279 million and HKD 295 million, reflecting an increase of approximately 30.1% to 37.6% compared to HKD 214 million for the first half of 2024 [1]

Core Viewpoint - Modern Dental (03600) shares rose over 10% following a positive earnings forecast, indicating strong anticipated growth in revenue and profit for the first half of 2025 [1] Financial Performance Summary - The company expects revenue for the first half of 2025 to be between HKD 1.775 billion and HKD 1.85 billion, representing an increase of approximately 4.3% to 8.7% compared to HKD 1.702 billion for the first half of 2024 [1] - EBITDA for the first half of 2025 is projected to be between HKD 430 million and HKD 470 million, reflecting an increase of approximately 14.5% to 25.1% from HKD 376 million in the first half of 2024 [1] - Net profit for the first half of 2025 is anticipated to range from HKD 279 million to HKD 295 million, marking an increase of approximately 30.1% to 37.6% compared to HKD 214 million for the first half of 2024 [1]

Core Viewpoint - Modern Dental (03600) anticipates revenue growth for the first half of 2025, driven by natural growth and the acquisition of Hexa Ceram, with significant increases in EBITDA and net profit expected [1][2] Group 1: Financial Projections - The expected revenue for the first half of 2025 is projected to be between HKD 1.775 billion and HKD 1.85 billion, representing an increase of approximately 4.3% to 8.7% compared to HKD 1.702 billion in the first half of 2024 [1] - The anticipated EBITDA for the first half of 2025 is expected to range from HKD 430 million to HKD 470 million, which is an increase of approximately 14.5% to 25.1% from HKD 376 million in the first half of 2024 [1] - The projected net profit for the first half of 2025 is expected to be between HKD 279 million and HKD 295 million, marking an increase of approximately 30.1% to 37.6% from HKD 214 million in the first half of 2024 [1] Group 2: Growth Drivers - Revenue growth is primarily attributed to the company's ongoing natural growth, particularly in Europe and Australia [1] - The increase in EBITDA and net profit is also due to the higher proportion of digital solution cases leading to improved operational efficiency [2] - Favorable exchange rate movements, including the appreciation of the Euro and Australian Dollar against the Renminbi and Hong Kong Dollar during the period from January to June 2025, have contributed positively [2] - The acquisition of Hexa Ceram, Thailand's largest dental laboratory, has accelerated growth [1][2]

Group 1 - The A-share dental medical sector experienced a significant rise at the beginning of trading, with Haocen Medical hitting the daily limit and closing up [1] - Aidi Te rose over 5%, while Kanghui Pharmaceutical, Yueshin Health, Zhenghai Biological, and Guoci Materials all increased by more than 2.5% [1]

Core Insights - Modern Dental (03600.HK) is actively implementing multi-dimensional strategies to capture market opportunities and increase sales despite a challenging macroeconomic environment [1] - The acquisition of Thailand's largest dental laboratory, Hexa Ceram Company Limited, is expected to enhance the company's product offerings and market coverage, allowing it to outperform domestic and international competitors [1] - The company is leveraging its production facilities in Thailand, Vietnam, and Dongguan to demonstrate resilience in an uncertain international trade environment and capitalize on global digitalization trends [1] Financial Performance - For the three months ending March 31, 2025, the total revenue of the group was approximately HKD 881.11 million, representing an increase of about 5.3% compared to HKD 837.00 million for the same period in 2024 [1] - The total sales volume increased by approximately 26.6% to about 672,000 units for the three months ending March 31, 2025, compared to approximately 531,000 units for the same period in 2024 [2] - Excluding sales from Hexa Ceram, the group's sales volume increased by about 0.9% to approximately 536,000 units, while excluding Micro Dental and Hexa Ceram, the sales volume rose by about 2.1% to approximately 479,000 units [2] Digital Solutions - The contribution from Hexa Ceram included approximately 14,298 cases of digital solutions, with the total number of digital solution cases produced in China, Thailand, and Vietnam increasing to about 223,587 cases, a rise of 28.4% compared to approximately 174,193 cases in the same period of 2024 [2] - The increase in digital solution cases is attributed to more customers adopting intraoral scanners [2]

Summary of Zimvi's Conference Call Company Overview - **Company**: Zimvi - **Industry**: Dental Implants and Digital Dentistry - **Key Products**: TSX implant, T3 Pro implant, Real Guide software, Implant Concierge, Puros Allografts, Immediate Molar Implant Core Points and Arguments 1. **Market Opportunity**: In the U.S., there are approximately 8 million candidates for tooth replacement, but only 25% receive dental implants, indicating significant growth potential in the market [4][5][6] 2. **Adoption and Education**: Zimvi focuses on increasing adoption of dental implants through training and education for both staff and referring dentists, emphasizing the importance of clinical outcomes and customer experience [5][6][7] 3. **Product Innovation**: 43% of Zimvi's sales come from products launched in the last three years, showcasing a strong innovation pipeline [9][58] 4. **Digital Dentistry**: The company is investing in digital solutions, including AI and cloud-based software, to enhance workflow and patient experience, with Real Guide software seeing a 39% growth in 2024 [10][24][29] 5. **Financial Performance**: Despite headwinds, Zimvi reported a 41% improvement in EBITDA and a 238% increase in EPS, indicating strong operational efficiency [35][36] 6. **Growth Projections**: For the full year, Zimvi anticipates flat to 3% growth in top-line revenue, with adjusted EBITDA growth of 17% and adjusted EPS growth of 31% to 55% [37] Additional Important Insights 1. **Market Dynamics**: The dental implant market is underpenetrated, and Zimvi aims to capture more market share through new product introductions and improved customer relationships [8][12] 2. **Full Arch Market**: Zimvi has increased its share in the full arch market from 5% to approximately 8.5-9%, with plans to further enhance this segment [22][44] 3. **Cost Management**: The company has improved gross margins by 360 basis points through cost reductions and operational efficiencies, with aspirations to reach over 70% gross margin in the long term [50][52] 4. **Pent-Up Demand**: There is potential for pent-up demand in the dental market as consumer sentiment improves and interest rates decrease, which could lead to accelerated growth [54][56] 5. **Customer Retention**: The renewal rate for Real Guide software exceeds 90%, indicating strong customer loyalty and satisfaction [61] Conclusion Zimvi is positioned for growth in the dental implant market through strategic product innovation, digital transformation, and operational efficiencies. The company is optimistic about capturing additional market share and improving financial performance in the coming years.

Core Viewpoint - The article highlights the growing trend of medical tourism from Russia to China, particularly in cities like Heihe, where Russian patients seek dental and traditional Chinese medicine services due to lower costs and better service quality compared to Russia [3][4][5]. Medical Tourism Growth - Medical tourism in border cities like Heihe and Suifenhe is attracting a significant number of Russian patients, especially for dental care and traditional Chinese medicine [3][4]. - The cost of dental procedures in China is approximately one-third of that in Russia, making it a financially attractive option for Russian patients [4][10]. - In 2024, the number of Russian visitors to China reached 2.78 million, with a significant increase in flight connections facilitating this trend [5][10]. Economic Context - The depreciation of the Russian ruble and high inflation rates have led to a decline in disposable income for many Russians, prompting them to seek more affordable medical options abroad [4][44]. - Despite a reported GDP growth of 4.1% in Russia for 2024, the economy is primarily driven by defense spending, with consumer spending under pressure [4]. Local Impact - The influx of Russian patients has created a burgeoning medical service industry in Heihe, with local businesses adapting to cater to this new clientele [10][11]. - The local economy in Heihe has seen a growth of 26.48% in the tertiary sector in 2024, largely driven by services catering to Russian tourists [10]. Cultural Exchange - The article notes a cultural exchange where Russian patients are increasingly engaging with Chinese medical practices, such as acupuncture and traditional therapies, which they find effective [18][36]. - Russian patients often express satisfaction with the services received in China, leading to repeat visits and recommendations among their peers [46]. Challenges and Adaptations - The article discusses the challenges faced by local businesses in adapting to the changing economic landscape, including the need to adjust pricing strategies to accommodate the reduced spending power of Russian clients [44][46]. - Communication barriers remain a challenge, with many Russian patients relying on translation services to navigate medical consultations and treatments [34][35].